Prognostic nomogram for patients with non-metastatic HER2 positive breast cancer in a prospective cohort

Abstract

We developed and validated a novel nomogram for predicting overall survival in patients with non-metastatic HER2 positive breast cancer, which presented a favorable discrimination ability. This model may assist clinical decision making and patient-clinician communication in clinical practice.